↓ Skip to main content

Oncotarget

Article Metrics

Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer

Overview of attention for article published in Oncotarget, July 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
11 news outlets
twitter
11 tweeters
facebook
1 Facebook page
video
1 video uploader

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
16 Mendeley
Title
Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
Published in
Oncotarget, July 2021
DOI 10.18632/oncotarget.28014
Pubmed ID
Authors

Tara Williamson, Michelle Carvalho de Abreu, Dimitri G. Trembath, Cory Brayton, Byunghak Kang, Thais Biude Mendes, Paulo Pimentel de Assumpção, Janete M. Cerutti, Gregory J. Riggins

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 19%
Student > Doctoral Student 3 19%
Student > Ph. D. Student 2 13%
Other 1 6%
Student > Bachelor 1 6%
Other 0 0%
Unknown 6 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 25%
Medicine and Dentistry 4 25%
Chemistry 1 6%
Chemical Engineering 1 6%
Unknown 6 38%

Attention Score in Context

This research output has an Altmetric Attention Score of 80. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2022.
All research outputs
#466,889
of 23,408,972 outputs
Outputs from Oncotarget
#131
of 14,407 outputs
Outputs of similar age
#12,768
of 440,054 outputs
Outputs of similar age from Oncotarget
#3
of 70 outputs
Altmetric has tracked 23,408,972 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,407 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,054 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.